ENTITY
Dr. Reddy's Laboratories

Dr. Reddy's Laboratories (DRRD IN)

132
Analysis
Health CareIndia
Dr. Reddy's Laboratories Limited provides a complete range of pharmaceutical services. The Company manufactures bulk drugs and formulations including verapamil and cephalexin. The Company also manufactures and exports molecules such as norfloxacin, ciprofloxacin, and varieties of semi-synthetic penicillin. The Company markets its products in India and around the world.
more
Refresh
08 Feb 2024 10:16

Agilus Diagnostics Limited Pre-IPO - Still Recovering from COVID

Agilus Diagnostics Limited (SRLL IN) is looking to raise around US$200m in its upcoming India IPO. In this note, we talk about the company's past...

Logo
444 Views
Share
bearishInfosys Ltd
06 Feb 2024 06:50

India: Free Float Changes & Passive Flows in February

Changes to shareholding patterns could lead to changes in float for some stocks in local/global indices. Passive trackers will need to trade over 3...

Logo
412 Views
Share
06 Feb 2024 05:16

Concord Biotech's US$650m Lock-Up Expiry - Some Could Be Tempted to Book Multi-Bagger Gains

Concord Biotech Ltd (658823Z IN) listed in India on 18th Aug 23. Coming up for six-month lockup expiry on 7th Feb 24 are the firm’s pre-IPO...

Logo
267 Views
Share
24 Jan 2024 07:34Broker

Pharmaceuticals: US Generic Growth to Stay, Selective on Structural Play

The pharmaceutical sector, emerging from the volatility of the past two post-pandemic and geopolitically tumultuous years, is now on a recovery...

Logo
211 Views
Share
15 Dec 2023 11:28

NIFTY200 Momentum30 Index Rebalance: 18 Changes a Side, 58% Turnover, Momentum Intact

The adds and deletes have performed in line since announcement of the changes a little over a week ago. With 10 trading days to implementation,...

Logo
1.1k Views
Share
x